Xenon Pharmaceuticals (XENE) Debt to Equity (2017 - 2020)
Xenon Pharmaceuticals (XENE) reported Debt to Equity of $0.08 for Q1 2020, down 49.15% year-over-year from $0.16 in Q2 2019, and down 50.64% quarter-over-quarter from $0.17 in Q4 2019.
Xenon Pharmaceuticals (XENE) Debt to Equity (2017 - 2020) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 4 years of Debt to Equity data on file, last reported at $0.08 in Q1 2020.
- Debt to Equity for Q1 2020 came in at $0.08, down 49.15% year-over-year; the trailing twelve-month figure through Mar 2020 was $0.08 (down 49.15% YoY), and the FY2019 annual result was $0.17, up 16.23% from the prior year.
- Debt to Equity slipped to $0.08 in Q1 2020 per XENE's latest filing, from $0.17 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.24 in Q1 2018 and troughed at $0.08 in Q1 2020.
- A 4-year average of $0.17 and a median of $0.18 in 2019 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2019 and 2020: Debt to Equity surged 54.24% in 2019, then sank 49.15% in 2020.
- A 4-year view of Debt to Equity shows it stood at $0.19 in 2017, then retreated by 23.24% to $0.15 in 2018, then climbed by 16.23% to $0.17 in 2019, then plunged by 50.64% to $0.08 in 2020.
- Business Quant data shows XENE's Debt to Equity at $0.08 in Q1 2020, $0.17 in Q4 2019, and $0.21 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 0.08 |
| Dec 31, 2019 | 0.17 |
| Sep 30, 2019 | 0.21 |
| Jun 30, 2019 | 0.18 |
| Mar 31, 2019 | 0.16 |
| Dec 31, 2018 | 0.15 |
| Sep 30, 2018 | 0.13 |
| Jun 30, 2018 | 0.23 |
| Mar 31, 2018 | 0.24 |
| Dec 31, 2017 | 0.19 |